RT @EyeVidence: #GeneTherapy for eye diseases are commonly AAV based and deliver…
[ad_1]
RT @EyeVidence: #GeneTherapy for eye diseases are commonly AAV based and delivered subretinal, which is associated with some risk. This stu…
[ad_2]
Source by Thomas Ciulla, MD, MBA